US Authorises Pfizer Vaccine For 12-15 Year Olds

Acting FDA commissioner Janet Woodcock described the move as a "significant step in the fight against the Covid-19 pandemic."

The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech Covid-19 vaccine on children aged 12 to 15 years old. Acting FDA commissioner Janet Woodcock described the move as a "significant step in the fight against the Covid-19 pandemic." "Today's action allows for a younger population to be protected from Covid-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic," Woodcock said in a statement. "Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our Covid-19 vaccine emergency use authorizations," she added.